Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis

Vaccine

Volumn 25, Issue 25, 2007, Pages 4801-4808

  Mawas, Fatme ^a   Ho, Mei Mei ^a   Huskisson, Rachel ^a   Saydam, Manolya ^a   Corbel, Michael J ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Immunogenicity; Otitis media; Physico chemical; Vaccine

Indexed keywords

OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN RLP4; OUTER MEMBRANE PROTEIN RLP6; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIMERIZATION; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; HAEMOPHILUS INFLUENZAE; IMMUNOGENICITY; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; OPTICS; OTITIS MEDIA; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ANIMALS; BACTERIAL VACCINES; BLOTTING, WESTERN; CELL PROLIFERATION; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; CYTOKINES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HAEMOPHILUS VACCINES; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MOLECULAR WEIGHT; MORAXELLA (BRANHAMELLA) CATARRHALIS; PHOSPHATES; SPLEEN; VACCINES, COMBINED; VACCINES, SYNTHETIC;

EID: 34249294412     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.026     Document Type: Article

References (15)

1. Leibovitz E., and Greenberg D. Acute otitis media in children: current epidemiology, microbiology, clinical manifestations, and treatment. Chang Gung Med J 27 7 (2004) 475-488
2. Klein J.O. Otitis media. Clin Infect Dis 19 5 (1994) 823-833
3. Murphy T.F. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev 60 2 (1996) 267-279
4. Foxwell A.R., Kyd J.M., and Cripps A.W. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev 62 2 (1998) 294-308
5. Green B.A., Vazquez M.E., Zlotnick G.W., Quigley-Reape G., Swarts J.D., Green I., et al. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun 61 5 (1993) 1950-1957
6. McMichael J.C., Fiske M.J., Fredenburg R.A., Chakravarti D.N., VanDerMeid K.R., Barniak V., et al. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect Immun 66 9 (1998) 4374-4381
7. Chen D., McMichael J.C., VanDerMeid K.R., Hahn D., Mininni T., Cowell J., et al. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect Immun 64 6 (1996) 1900-1905
8. Green B.A., Baranyi E., Reilly T.J., Smith A.L., and Zlotnick G.W. Certain site-directed, nonenzymatically active mutants of the Haemophilus influenzae P4 lipoprotein are able to elicit bactericidal antibodies. Infect Immun 73 7 (2005) 4454-4457
9. Mason K.W., Zhu D., Scheuer C.A., McMichael J.C., Zlotnick G.W., and Green B.A. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine 22 25-26 (2004) 3449-3456
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 5259 (1970) 680-685
11. Hotomi M., Ikeda Y., Suzumoto M., Yamauchi K., Green B.A., Zlotnick G., et al. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine 23 10 (2005) 1294-1300
12. Hotomi M., Yamanaka N., Shimada J., Suzumoto M., Ikeda Y., Sakai A., et al. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae. Int J Pediatr Otorhinolaryngol 65 2 (2002) 109-116
13. Cope L.D., Lafontaine E.R., Slaughter C.A., Hasemann Jr. C.A., Aebi C., Henderson F.W., et al. Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol 181 13 (1999) 4026-4034
14. Dagan R., Eskola J., Leclerc C., and Leroy O. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun 66 5 (1998) 2093-2098
15. Mawas F., Dickinson R., Douglas-Bardsley A., Xing D.K., Sesardic D., and Corbel M.J. Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model. Vaccine 24 17 (2006) 3505-3512